Literature DB >> 15533854

Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study.

Ali Judd1, Matthew Hickman, Steve Jones, Tamara McDonald, John V Parry, Gerry V Stimson, Andrew J Hall.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15533854      PMCID： PMC539846          DOI： 10.1136/bmj.38286.841227.7C

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators.

Authors:  Matthew Hickman; Vanessa Higgins; Vivian Hope; Mark Bellis; Kate Tilling; Angeline Walker; John Henry
Journal:  J Epidemiol Community Health       Date:  2004-09       Impact factor: 3.710

2.  Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine.

Authors:  J A Connell; J V Parry; P P Mortimer; J Duncan
Journal:  J Med Virol       Date:  1993-10       Impact factor: 2.327

3.  HIV incidence appears constant in men who have sex with men despite widespread use of effective antiretroviral therapy.

Authors:  Gary Murphy; Andre Charlett; Laura F Jordan; Natasha Osner; O Noel Gill; John V Parry
Journal:  AIDS       Date:  2004-01-23       Impact factor: 4.177

4.  Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots.

Authors:  Ali Judd; John Parry; Matthew Hickman; Tamara McDonald; Laura Jordan; Kim Lewis; Marcela Contreras; Geoff Dusheiko; Graham Foster; Noël Gill; Katie Kemp; Janice Main; Iain Murray-Lyon; Mark Nelson
Journal:  J Med Virol       Date:  2003-09       Impact factor: 2.327
  4 in total
  49 in total

1.  Hospital-based needlestick use and injuries by Dublin interns in 2010.

Authors:  P O'Sullivan; D M Seoighe; J F Baker; B J O'Daly; T McCarthy; S Morris
Journal:  Ir J Med Sci       Date:  2011-01-05       Impact factor: 1.568

2.  Injection drug users: the overlooked core of the hepatitis C epidemic.

Authors:  Brian R Edlin; Michael R Carden
Journal:  Clin Infect Dis       Date:  2006-01-20       Impact factor: 9.079

3.  Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection.

Authors:  L J Brant; M Hurrelle; M A Balogun; P Klapper; F Ahmad; E Boxall; A Hale; V Hollyoak; I B Ibrahim; W Irving; R Meigh; K J Mutton; B C Patel; W K Paver; S Pugh; C Taylor; A J Turner; M E Ramsay
Journal:  Epidemiol Infect       Date:  2006-07-13       Impact factor: 2.451

4.  Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities.

Authors:  Lucy Platt; Tim Rhodes; Ali Judd; Evgeniya Koshkina; Svetlana Maksimova; Natalia Latishevskaya; Adrian Renton; Tamara McDonald; John V Parry
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

Review 5.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

6.  Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C.

Authors:  G V Matthews; S T Pham; M Hellard; J Grebely; L Zhang; A Oon; P Marks; I van Beek; W Rawlinson; J M Kaldor; A Lloyd; G J Dore; P A White
Journal:  Clin Infect Dis       Date:  2011-01-31       Impact factor: 9.079

7.  Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior.

Authors:  Holly Hagan; Jennifer V Campbell; Hanne Thiede; Steffanie A Strathdee; Lawrence Ouellet; Mary Latka; Sharon Hudson; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2007-03-23       Impact factor: 4.492

8.  How can hepatitis C be prevented in the long term?

Authors:  Pedro Mateu-Gelabert; Carla Treloar; Víctor Agulló Calatayud; Milagros Sandoval; Juan Carlos Valderrama Zurián; Lisa Maher; Tim Rhodes; Samuel R Friedman
Journal:  Int J Drug Policy       Date:  2007-07-24

9.  Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Kristi Rüütel; Don C Des Jarlais
Journal:  Harm Reduct J       Date:  2009-02-20

10.  A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.

Authors:  Marie Jauffret-Roustide; Yann Le Strat; Elisabeth Couturier; Damien Thierry; Marc Rondy; Martine Quaglia; Nicolas Razafandratsima; Julien Emmanuelli; Gaelle Guibert; Francis Barin; Jean-Claude Desenclos
Journal:  BMC Infect Dis       Date:  2009-07-16       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.